Xytis Pharmaceuticals Ltd.
116 Gloucester Place
London
W1U 6HZ
United Kingdom
Website: http://www.xytis.com/
Email: Info@xytis.com
6 articles about Xytis Pharmaceuticals Ltd.
-
Xytis Pharmaceuticals Ltd. to Initiate First-In-Class Phase I Clinical Trials with Alpha 7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator XY4083
11/18/2008
-
Xytis Names Gordon H. Busenbark as Chief Financial Officer
10/19/2007
-
Xytis Pharmaceuticals Ltd. Enrolls First Patient in Phase II Clinical Study With Anatibant (XY2405) for Traumatic Brain Injury
3/13/2007
-
Xytis Pharmaceuticals Ltd. Begins Phase II Clinical Study With Anatibant (XY2405) For Traumatic Brain Injury
1/9/2007
-
Xytis Pharmaceuticals Ltd. Names Dr. Vincent F. Simmon President, Chief Executive Officer And Director
1/5/2007
-
Xytis Inc. Raises $24.5 Million In Series B Financing; Proceeds To Conduct Phase II/III Clinical Trials In Traumatic Brain Injury; Phase I/II In Schizophrenia
1/9/2006